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During normal development as well as in diseased states such as cancer, extracellular “niches” often provide
cues to proximal cells and activate intracellular pathways. Activation of such signaling pathways in turn
instructs cellular proliferation and differentiation. In the Caenorhabditis elegans gonad, GLP-1/Notch signaling
instructs germ line stem cells to self-renew through mitotic cell division. As germ cells progressively move out
of the niche, they differentiate by entering meiosis and eventually form gametes. In this model system, we
uncovered an unexpected role for the dynein motor complex in promoting normal differentiation of prolifer-
ating germ cells. We demonstrate that dynein light chain 1 (DLC-1) and its partner, dynein heavy chain 1,
inhibit the proliferative cell fate, in part through regulation of METT-10, a conserved putative methyltrans-
ferase. We show that DLC-1 physically interacts with METT-10 and promotes both its overall levels and
nuclear accumulation. Our results add a new dimension to the processes controlled by the dynein motor
complex, demonstrating that dynein can act as an antiproliferative factor.
Caenorhabditis elegans germ cells proceed through a well-
orchestrated developmental program on their way to produc-
ing specialized gametes (23). The C. elegans gonad functions as
an assembly line organized with a distal-to-proximal polarity
with respect to the uterus (Fig. 1A). Proliferating germ cells,
including the germ line stem cells, reside in the distal region of
the gonad that forms the stem cell niche. These cells self-renew
through mitosis or, at a certain frequency, differentiate by
entering meiosis and give rise to gametes after an extended
meiotic prophase (Fig. 1B). Proliferation of the distal germ
cells results in a net flux of germ cells toward the proximal end,
and it is thought that differentiation is a consequence of pro-
gressive displacement away from the stem cell niche (9, 33, 36).
The primary signal instructing germ cells to proliferate is
activation of the GLP-1/Notch signaling pathway in germ cells
through interaction with the somatic distal tip cell that ex-
presses the Notch ligand LAG-2, which provides the stem cell
niche (19, 20, 27). Mutations that disrupt GLP-1/Notch recep-
tor function result in premature differentiation and meiotic
entry of germ line stem cells (1), while gain-of-function muta-
tions that hyperactivate GLP-1/Notch cause germ line tumors
characterized by germ cell overproliferation (5, 43).
Multiple factors act to restrain GLP-1-dependent germ
cell proliferation (19, 27). The C. elegans mett-10 gene was
initially characterized as an inhibitor of germ cell prolifer-
ative fate but was also shown to play a role in promoting
progression through mitotic cell division and meiotic devel-
opment (13). mett-10 encodes a putative methyltransferase
that is conserved in higher eukaryotes and a loss-of-function
mutation that disrupts the binding pocket for S-adenosyl-
methionine and compromises the balance between prolifer-
ative and meiotic fates (13, 35; http://www.rcsb.org/pdb
/explore.do?structureId2H00). METT-10 accumulates in
nuclei as germ cells enter meiosis, consistent with its role in
inhibiting proliferative fate and promoting meiotic progres-
sion (13). However, it is unclear how METT-10 nuclear
accumulation is controlled or if it is essential for METT-10
activity.
We find that inhibition of proliferative fate is also regulated
by dynein light chain 1 (DLC-1) and its partner, dynein heavy
chain 1 (DHC-1); DLC-1 upregulates mett-10 mRNA levels
and promotes the nuclear accumulation of the METT-10 pro-
tein. Cytoplasmic dynein is a large, microtubule-associated mo-
tor complex that traffics organelles, proteins, and RNAs to-
ward microtubule minus ends (7, 25, 58). Dynein is required
for many cellular processes, including execution of mitotic cell
division, a process necessary for cell proliferation (17, 25, 51).
Thus, the unexpected role of dynein in the inhibition of germ
cell proliferative fate demonstrates that proliferative fate is
genetically separable from the act of mitotic cell division itself
and addresses how cellular machinery can implement develop-
mental programs.
MATERIALS AND METHODS
General worm culture and genetics. Standard procedures for culture and
genetic manipulation of C. elegans strains were followed (6). Strain constructions
were verified by single-worm PCR and sequencing of alleles. To this end, we
identified a molecular lesion in dhc-1(js319) (29) as an AG3AA mutation in the
splice acceptor for exon 13.
Alleles used in this study are listed by chromosome as follows. For chromo-
some I, rrf-1(pk1417), dhc-1(js319), and dhc-1(or195) were used; for chromo-
some III, mett-10(oz36) (antimorph), mett-10(g38) (hypomorph), mett-
10(tm2697) (hypomorph), mett-10(oj32) (hypomorph), mett-10(ok2204) (null),
glp-1(oz264gf), and glp-1(bn18ts) were used.
Integrated transgenes used in this study are listed as follows: ozIs7[pmett-
10:mett-10::gfp; unc-119()], ozIs9[pmett-10:mett-10(5A)::gfp; unc-119()] (low
protein and mRNA expression, as measured by immunoprecipitation [IP] and quan-
titative reverse transcription-PCR [qRT-PCR]) (data not shown), ozIs11[pmett-
10:mett-10(5A)::gfp; unc-119()] (high protein and mRNA expression, as measured
by IP and qRT-PCR) (data not shown), ozIs15[pmett-10:mett-10(oj32, 5A)::gfp; unc-
119()] (line 1), ozIs16[pmett-10:mett-10(oj32, 5A)::gfp; unc-119()] (line 2),
ozIs20[pmett-10:mett-10(-NLS, 5A)::gfp; unc-119()] (line 1), and ozIs21[pmett-10:
mett-10(-NLS, 5A)::gfp; unc-119()] (line 2).
Extrachromosomal arrays used in this study are listed as follows: ozEx66
[pmett-10:mett-10::gfp; unc-119()], ozEx69 [pmett-10:mett-10(-NLS)::gfp; unc-
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119()], ozEx67 [pmett-10:mett-10(5A)::gfp; unc-119()], ozEx72 [pmett-10:mett-
10(-NLS, 5A)::gfp; unc-119()], and ozEx73 [pmett-10:mett-10(oz36)::gfp; unc-
119()].
Immunohistochemistry. Germ line dissection, fixation, and staining were car-
ried out as previously described (31). The antibodies used were as follows:
monoclonal mouse anti-green fluorescent protein (anti-GFP) (mAb3E6) from
Invitrogen (catalog no. A-11120) at a dilution of 1/100 and rabbit anti-DLC-1 at
a dilution of 1/10 (see below), donkey anti-mouse antibody–Alexa 594, goat
anti-rabbit antibody–Alexa 488, and goat anti-rabbit antibody–Alexa 594 at a
dilution of 1/400, obtained from Molecular Probes (Invitrogen, Carlsbad, CA).
Labeling of DNA synthesis with the nucleotide analog 5-ethynyl-2-deoxyuridine
(EdU) (49) was done by feeding worms with bacteria containing EdU (13). EdU
detection and costaining with antibodies were carried out as previously described
(13).
Generation of anti-DLC-1 antibody and quantification of DLC-1 levels. To
generate the glutathione S-transferase (GST)–DLC-1 fusion protein, full-length
DLC-1 was cloned into the pGEX-5x-3 vector (catalog no. 27-4586-01; GE
Healthcare Life Sciences). Inductions were carried out in Escherichia coli strain
BL21(DE3) (Sigma, MO). From an overnight starter culture grown at 30°C,
cultures were diluted and grown at 37°C until they reached an optical density at
600 nm of 0.5. Cells were induced with 1 mM IPTG (isopropyl--D-thiogalacto-
pyranoside) for 3 h at 37°C. Cells were harvested, and GST–DLC-1 was then
extracted essentially as described previously (50) and injected into rabbits ob-
tained from Pocono Rabbit Farm & Laboratory (Canadensis, PA). Sera were
affinity purified against a His6–DLC-1 fusion protein. To make His6–DLC-1,
DLC-1 was amplified from pGEX(DLC-1) and cloned into pTRCHIS (catalog
no. K4410-01 and K4410-40; Invitrogen). pTRCHIS(DLC-1) was transformed
into BL21(DE3) cells, and cultures were induced similarly to GST–DLC-1.
His6–DLC-1 was extracted under native conditions using Ni-nitrilotriacetic acid
agarose (catalog no. 30210; Qiagen). His6–DLC-1 was subsequently coupled to
cyanogen bromide-activated Sepharose (catalog no. C9142; Sigma, MO), and
antibody purification was carried out essentially as previously described (24).
Specificity was determined both by Western blotting (where antibody recognizes
a single 10-kDa band) (data not shown) and by antibody staining of germ lines
and intestines from animals treated with and without dlc-1 RNA interference
(RNAi).
For quantification of DLC-1 levels (Fig. 2J), raw images of DLC-1 staining
were imported into ImageJ, germ lines were traced, and the average pixel
intensity was calculated. All pixel intensities were then normalized to represent
the percent knockdown by dividing the pixel intensity for the sample by the
average DLC-1 pixel intensity for glp-1(oz264) germ lines fed control RNAi and
multiplying by 100.
Image capture and processing. Fluorescence micrographs were taken on a
Zeiss compound microscope using Axioplan 2.0 imaging software and a
Hamamatsu camera. Each dissected and stained gonad was captured as a mon-
tage, with overlapping cell boundaries. The montages were then assembled in
Adobe Photoshop CS3 and processed identically. The boundary of each montage
was processed using a feather tool of 20 pixels for each image. Confocal images
were captured on a PerkinElmer UltraView confocal microscope using a z-step
of 0.3 m.
RNAi of METT-10 yeast two-hybrid interactors. RNAi clones were either
purchased from Open Biosystems or generated by PCR amplification and clon-
ing of 1-kb exonic sequences into the pPD128.36 double T7 promoter vector,
sequenced to verify identity, and transformed into the E. coli host HT115(DE3).
RNAi feeding in rrf-1(pk1417), rrf-1(pk1417) glp-1(oz264gf), and rrf-1(pk1417)
mett-10(oz36) backgrounds at the permissive temperature (20°C) was performed
as previously described (31). F1 L4 hermaphrodites were transferred onto fresh
RNAi plates and scored quantitatively for germ line tumors 48 h later by differ-
ential interference contrast (DIC) microscopy. In the course of the screening, it
came to our attention that mett-10 mutants are relatively resistant to germ line
RNAi.
Construction of transgenes and generation of transgenics. The initial
mett-10::gfp construct includes 1.6 kb upstream and 1.9 kb downstream of the
METT-10 coding region, with GFP (intervening sequence):FLAG inserted im-
mediately before the translational stop cloned into the pMM016 vector contain-
ing the transformation marker unc-119 (13). Mutations of the mett-10 coding
region, including nuclear localization signal (NLS) deletion, DNASQ3AAAAA,
methyltransferase mutation (G110R) mimicking the mett-10(oj32) mutation (13),
and deletion of coding sequences downstream to the mett-10(oz36) premature
stop codon, were done with sewing PCR (22). To create low-copy-number-
integrated transgenic lines, the microparticle bombardment method was used
(45). Generation of extrachromosomal arrays was done by injection of
pMM016(mett-10) plasmids at a concentration of 40 ng/l into unc-119(ed3)
worms.
GST pulldowns. Full-length METT-10 (C. elegans coding region ZK1128.2a),
METT-10 (N terminal) (amino acids [aa] 1 to 271), or METT-10 (C terminal)
(aa 272 to 479) was amplified from N2 Bristol cDNA and cloned into pTRCHIS
(catalog no. K4410-01, K4410-40; Invitrogen), sequenced, and transformed into
BL21(DE3) (Sigma, MO) cells for expression. Proteins were expressed under the
same conditions as GST–DLC-1 (see above). For GST pulldowns, bacterial
extracts were resuspended in phosphate-buffered saline plus protease inhibitors
and sonicated. Cleared cell extracts were added directly to 5 g of GST–DLC-1
already bound to glutathione-Sepharose in 20 mM Tris at pH 7.5, 500 mM NaCl,
0.5% NP-40, and 1 protease inhibitors. For binding to GST–METT-10, signif-
icantly less protein was used (100 to 200 ng), as METT-10 does not express well
in vitro. Binding reactions were carried out overnight at 4°C and washed four
times with 10 mM Tris at pH 7.5, 150 mM NaCl, and 0.1% NP-40. Western blot
analysis using an anti-His6 antibody (catalog no. 27-4710-01; Amersham Bio-
sciences) was performed with beads boiled in sodium dodecyl sulfate sample
buffer with -mercaptoethanol. Point mutations in METT-10 and DLC-1 were
generated using sewing PCR or site-directed mutagenesis.
IP and Western analysis. To generate enough worms for IP-Western analysis
of METT-10:GFP (flag), we resuspended worms from 10 60-mm overgrown
plates of each transgenic line in 5% lactose and 10 OP50 or 1 bacteria
expressing double-stranded RNA and plated these worms onto 10 100-mm
plates, which were shifted to 25°C to maximize transgene expression. After 2
days, worms were washed off in phosphate-buffered saline, and extracts and IPs
were carried out essentially as described previously (18). Immunoprecipitated
proteins were analyzed using Western blotting with both mouse monoclonal
anti-FLAG M2 (catalog no. F1804; Sigma) and rabbit anti-GFP (catalog no.
FIG. 1. (A) Fluorescence micrograph of a dissected, DAPI (4,6-
diamidino-2-phenylindole)-stained adult C. elegans hermaphrodite
germ line, with schematic. In the distal region, proliferating germ cells
(2) reside in close contact with the somatic distal tip cell (1). At the
transition zone (3), germ cells enter meiosis and proceed through
meiotic prophase (4) to give rise to sperm (6) and oocytes (5).
(B) Scheme depicting the decision that C. elegans germ line stem cells
make between maintaining a proliferative fate (green) and differenti-
ating (red) to produce gametes.
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A11122; Invitrogen) antibodies. For loading controls, we used mouse anti--
tubulin (catalog no. T9026; Sigma) and anti-CGH-1 (a gift from David Green-
stein). CGH-1 stands for conserved germ line helicase and is a protein that is
abundantly expressed throughout the germ line, localizing to both the cytoplasm
and P granules (39).
mRNA quantification. To measure mett-10:gfp transgene expression relative to
endogenous, each mett-10::gfp transgene was crossed into the mett-10(ok2204)
background, which contains a large deletion of the mett-10 5 region. Total RNA
was isolated using Trizol (Invitrogen), treated with DNase I (Epicentre), chlo-
roform extracted, ethanol precipitated, and dissolved in water. cDNA was syn-
thesized using random hexamer primers and SuperScript VILO reverse trans-
criptase (Invitrogen). Transcripts were quantified using Sybr green real-time
PCR (Clontech) and gene-specific primers (see below) calibrated with genomic
DNA. mRNA levels were calculated, adjusting for amplification efficiency (44)
and normalizing to internal cgh-1 or act-3 transcripts and external genomic DNA
standards. Standard deviations were calculated using all PCR replicates from all
biological replicates.
The following primers were used for quantitative RT-PCR, with the forward
primer sequence listed first, followed by the reverse primer sequence: mett-10,
TGATATTGGCACCGGAACATCGTG and CATCTCCGTCAGTGGCAAT
GAACT; dlc-1, TGGCATTGCATCGTCGGAAGAAAC and AGACTTGAAT
AGCAGGATGGCGAC; act-3, TCTTGACTTGGCTGGACGTGATCT and
TGATGTCACGGACGATTTCACGCT; and cgh-1, ATCAACTTCCTCCCAA
AGGAGCG and TCATACGGCTTGTGCATGTGCTTC.
RESULTS
DLC-1 inhibits germ cell proliferative fate. In a screen for
proteins that inhibit germ cell proliferative fate, we discovered
that partial RNAi depletion of dlc-1 enhanced germ line tumor
formation in a genetic background sensitized by excessive glp-1
activity [glp-1(oz264gf)] (Fig. 2A) (26). DLC-1 is an LC8-type
dynein light chain and a component of the dynein motor com-
plex that participates in multiple processes, including mitotic
cell division (16, 25, 37, 42, 58).
Although DLC-1 depletion causes germ line tumors in the
glp-1(gf)-sensitized genetic background (Fig. 2B, D, and E), it
disrupts mitotic and meiotic processes in wild-type worms. In
addition to apparent polyploid nuclei, which are larger and
contain more DNA, many oocytes contained unpaired chro-
mosomes (compare Fig. 2B and C). Our observation of
polyploidy is consistent with previously described roles for
dynein in mitotic cell division across taxa (16, 25, 37, 42, 58),
while the observation of unpaired diakinetic chromosomes ex-
tends those of previous studies that have demonstrated a role
for dynein in mediating homologous chromosome pairing in
fission yeast (12, 60, 61). At first glance, these findings appear
paradoxical because the germ line tumors in the glp-1 gain-of-
function background require additional mitotic divisions. How-
ever, when we assessed the degree of DLC-1 knockdown using
antibody staining (Fig. 2F to H), we found that the role of
DLC-1 in inhibiting proliferative fate is uncovered in the glp-1
mutant background because only a slight decrease in DLC-1 is
needed to enhance the tumorous phenotype of the glp-
1(oz264gf) mutant without causing mitotic defects. In contrast,
more-severe knockdown affects both cell fate and cell division,
leading to polyploidy (Fig. 2F to J).
While dynein light chains function within the context of the
dynein motor complex, other functions independent of the
motor complex have been described (3, 21, 28, 46). There are
multiple light chains, but among the multiple dynein light
chains we tested, including the closest dlc-1 paralog, dlc-2, the
Roadblock-type light chain dyrb-1, and the Tctex-type light
chain dylt-1, only RNAi of dlc-1 enhanced glp-1(oz264gf) over-
proliferation (Fig. 2A). It is possible that we did not achieve an
optimal level of knockdown to reveal an overproliferation phe-
notype for the other light chains. Strikingly, RNAi-mediated
depletion of DHC-1, the essential motor component of dynein
motor complex activity (17), also increased tumor formation,
suggesting that it plays a role in proliferative fate specification
(Fig. 2A). We conclude, therefore, that DLC-1 affects the
proliferative fate decision in the context of the motor complex,
although it may be unique among the light chains in doing so.
The dynein motor complex promotes normal localization
and levels of METT-10. One reason we suspected that DLC-1
might play a role in the germ cell proliferative fate decision was
that a genome-wide yeast two-hybrid screening of conserved
worm proteins (32) suggested that DLC-1 may be a functional
partner of another protein that inhibits proliferative fate, the
METT-10 putative methyltransferase (13). Loss of METT-10
also enhances germ cell proliferation and formation of germ
line tumors in the glp-1(oz264gf)-sensitized genetic background
(13). METT-10 accumulates in nuclei as cells enter meiosis, in
line with its functions in inhibiting proliferative fate and pro-
moting meiotic development (Fig. 3A). Our finding that
DLC-1 depletion enhances the glp-1(oz264gf) tumorous phe-
notype, coupled with the established role of dynein in traffick-
ing proteins to the nucleus (16, 25, 37, 42), suggested that
DLC-1 may inhibit germ cell proliferative fate through regu-
lation of METT-10 nuclear accumulation. Using RNAi, we
found that DLC-1 knockdown decreases accumulation of a
METT-10::GFP fusion protein in nuclei throughout the germ
FIG. 2. dlc-1 functions to inhibit proliferative fate in the C. elegans germ line. (A) RNAi against dlc-1 and dhc-1 enhances tumor formation in
the glp-1(oz264gf) background at 20°C, while RNAi against other light chains does not. dlc-2, paralog of dlc-1; dylt-1, Tctex-type dynein light chain;
dyrb-1, Roadblock-type light chain. Two-tailed P values were determined using Fisher’s exact test. (B, C) In wild-type germ lines (B), as well as
in dlc-1 RNAi of control animals (C), a 3-h pulse of the nucleotide analog EdU, which incorporates during DNA synthesis, labels (green) only the
very distal end (left) of the germ line, although dlc-1 RNAi causes abnormal nuclei containing large, dense DNA bodies (white arrows) and
unpaired chromosomes in diakinesis to occur. Insets show chromosomal morphology of diakinetic oocytes, with six sets of bivalents in oocytes from
control germ lines (B) but 12 univalents for dlc-1 RNAi (C). (D, E) dlc-1 RNAi causes tumor formation and EdU incorporation throughout the
germ line in glp-1(oz264gf) (E), while the glp-1(oz264gf) mutant on its own has only a marginal increase in EdU incorporation (D). (F to H) Staining
against DLC-1 (green) in glp-1(oz264gf) animals treated with double-stranded RNA targeting either gfp as a control (F) or dlc-1 (G, H). (G) A
tumorous germ line with partial DLC-1 knockdown and unaffected nuclear morphology; (H) a tumorous germ line with stronger DLC-1
knockdown and abnormal nuclear morphology. (I) This inset from panel H highlights the large size of abnormal nuclei. Solid arrows indicate large,
DNA-dense (abnormal) nuclei, and feather arrows indicate nuclei of relatively normal size. (J) Quantification of DLC-1 levels by pixel intensity
for glp-1(oz264gf); gfp(RNAi) germ lines (white bar), glp-1(oz264gf); dlc-1(RNAi) tumorous germ lines with normal nuclear morphology (black bar),
and glp-1(oz264gf); dlc-1(RNAi) tumorous germ lines with abnormal nuclear morphology (gray bar). Error bars indicate the standard errors of the
means for the results. All scale bars  20 m. Tum, tumorous; wt, wild type.
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line and also in somatic cells (Fig. 3A and B; also data not
shown).
To confirm that DLC-1 functions with the motor complex to
promote METT-10 nuclear accumulation, we tested whether re-
ductions in DHC-1 activity also resulted in a decrease in nuclear
METT-10. We found that in a genetic background with decreased
DHC-1 function [dhc-1(or195)] (51), METT-10::GFP nuclear ac-
cumulation is delayed, with a strong nuclear signal only in late
pachytene rather than near the transition zone as occurs in wild-
type germ lines, in more than 50% of germ lines (Fig. 3C). This
finding indicates that the dynein motor complex promotes
METT-10 nuclear accumulation.
In addition to diminished nuclear localization, overall stain-
ing intensity for METT-10::GFP is reduced upon DLC-1 de-
pletion, suggesting that DLC-1 also promotes or maintains the
total METT-10 protein level (Fig. 3B). Indeed, IP of
METT-10::GFP from animals treated with control RNAi or
RNAi against dlc-1 revealed that total METT-10::GFP levels
are reduced by partial DLC-1 depletion (Fig. 3D). This reduc-
tion does not reflect a decrease in germ line size, because the
levels of a ubiquitous germ line protein, CGH-1 (39), were
unchanged (Fig. 3D).
DLC-1 regulates mett-10 RNA levels. We considered two
potential mechanisms by which DLC-1 could regulate total
METT-10 protein accumulation. LC8-type dynein light chains
regulate transcription (46, 47) and also interact directly with
various proteins to regulate their subcellular localization
and/or dimerization status, which could alternatively affect
protein stability (2, 10, 38, 52). To address whether DLC-1
regulates METT-10 at the mRNA level, we tested the effect of
DLC-1 depletion on levels of METT-10 mRNA using qRT-
PCR and found that knockdown of DLC-1 results in four- to
fivefold-higher reductions in mett-10 mRNA relative to the
germ line ubiquitous gene cgh-1 (Fig. 3E). Thus, DLC-1 pro-
motes overall METT-10 mRNA levels potentially through a
transcriptional mechanism.
DLC-1 binds METT-10 in vitro. We tested if DLC-1 inter-
acts directly with METT-10 using GST pulldown affinity chro-
matography and found that His6-tagged METT-10 binds GST–
DLC-1 in vitro (Fig. 4A). We used a series of amino acid
substitution mutations in DLC-1 to see if its interaction with
METT-10 requires the same amino acid domain shown to
mediate LC8-type dynein light chain interaction with potential
“cargo” proteins and dynein intermediate chains (10, 38). In-
deed, disruption of amino acid residues F62, T67, and F73
greatly reduced binding to METT-10, while mutation of H68
did not affect binding (Fig. 3A), showing that the interaction
FIG. 3. DLC-1 promotes METT-10 nuclear accumulation. (A) METT-10::GFP expression in a wild-type germ line. (B) dlc-1 RNAi causes a
decrease in METT-10::GFP accumulation, abnormal nuclear morphology (left), and unpaired chromosomes in diakinesis (right, yellow arrows).
(C) METT-10::GFP nuclear accumulation is delayed in the dhc-1(or195) mutant background, with nuclear accumulation observed only in late
pachytene. Solid and feather arrows indicate nuclei positive and negative for METT-10::GFP, respectively. (D) IP-Western blotting for
METT-10::GFP levels in whole animals subject to both control (empty vector) RNAi and dlc-1(RNAi). CGH-1 is a germ line ubiquitous protein.
(E) qRT-PCR for dlc-1 (top) and mett-10 (bottom) normalized to cgh-1 mRNA levels. RNAi was carried out in the rrf-1(pk1417) background,
which retains RNAi only in the germ line.
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between DLC-1 and METT-10 is similar to previously charac-
terized interactions (10, 38).
In the course of analyzing the physical interaction between
METT-10 and DLC-1, we discovered that METT-10 strongly
interacts with itself. We noticed a sodium dodecyl sulfate-
stable supershifted band in the gel electrophoresis of some
METT-10 proteins equivalent in size to the expected size of a
dimer (Fig. 4B), in line with previous reports that some meth-
yltransferases require multimerization for function (34, 56).
The stable self-interaction domain of METT-10 maps to the
C-terminal region (aa 272 to 479), and a supershift was never
seen with a METT-10 N-terminal fragment (aa 1 to 271) alone
(Fig. 4B). To confirm that METT-10 binds to itself, we carried
out GST pulldown analysis between HIS6-tagged and GST-
tagged METT-10. We observed the supershifted band for
HIS6-tagged METT-10 pulled down by GST-tagged METT-10,
suggesting that METT-10 may exist in an oligomeric form (Fig.
4C). Interestingly, the putative METT-10 dimer is also pulled
down by DLC-1, indicating that the C-terminal interface by
which METT-10 interacts with itself is independent of the
interface used to bind DLC-1 (Fig. 4C).
DLC-1 and the METT-10 NLS act redundantly to ensure
METT-10 nuclear accumulation. The finding that DLC-1 in-
teracts with METT-10 raised the possibility that DLC-1 par-
ticipates directly in METT-10 nuclear accumulation. To ad-
dress whether DLC-1 promotes METT-10 localization through
direct binding, we needed to specifically test the contribution
of DLC-1 interaction to METT-10 nuclear accumulation in
vivo. To this end, we mapped the residues that interact with
DLC-1 in METT-10. Previous work showed that LC8-type
light chains interact with a short peptide sequence in their
target proteins, usually conforming to either a (S/K)XTQT or
GIQVD sequence motif (2, 4), but METT-10 does not have
either of these motifs. We thus tested a series of METT-10
C-terminal truncations (data not shown), followed by individ-
ual amino acid replacements in an eight-amino-acid region, for
FIG. 4. METT-10 binds DLC-1 in vitro. (A) GST–DLC-1 point mutants (Coomassie) were assayed for binding to full-length His6–METT-10
proteins. WT, wild type. (B) METT-10 can form multimers. Western blot (WB) analysis of bacterially expressed His6–METT-10 fusion proteins
reveals bands that run at the size of monomers () and dimers ($). The lowest band in lane 1 likely represents a METT-10 degradation product.
(C) A dimeric band (feathered arrow) is observed when full-length His6–METT-10 is pulled down with GST–DLC-1 and full-length GST–METT-
10. (D) Fine mapping of the DLC-1 binding domain of METT-10 using GST-pulldown analysis analogous to that shown in panel C. The identity
of individually mutated METT-10 residues are labeled on the left.
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their ability to interact with DLC-1 in GST pulldown experi-
ments. Mutation of METT-10 amino acid residues D420,
N421, S423, and Q424 to alanine severely compromised bind-
ing to DLC-1, thus defining the METT-10 motif that interacts
with DLC-1 as “DNASQ” (Fig. 4D).
To determine the effect of DLC-1 binding on METT-10
localization in vivo, we constructed a transgenic version of
METT-10::GFP in which the “DNASQ” motif was mutated to
“AAAAA” (5A mutant) (Fig. 5A) and compared the localiza-
tion of METT-10::GFP constructs within gonadal sheath cells,
which are large cells that express METT-10 at higher levels and
thus are easy to visualize. Wild-type METT-10::GFP is con-
centrated in the nucleus (Fig. 5B), and disruption of the
DNASQ motif that interacts with DLC-1 reduces, but does not
eliminate, nuclear METT-10::GFP (Fig. 5C).
In addition to the DLC-1 binding motif, METT-10 also con-
tains a potential nuclear localization sequence (ARKRAKA),
raising the possibility that this may act redundantly with the
DLC-1 binding site to enable METT-10 nuclear accumulation.
Supporting this idea, deletion of the putative METT-10 NLS
alone does not block nuclear entry (Fig. 5D), but simultaneous
disruption of both the NLS and the DLC-1 binding site makes
METT-10 predominantly cytoplasmic (Fig. 5E).
Cytoplasmic METT-10 rescues most mett-10 mutant pheno-
types. Identification of at least two pathways promoting
METT-10 nuclear accumulation enabled us to address if
METT-10 nuclear accumulation is essential in vivo and
whether the METT-10:DLC-1 physical interaction is vital to
METT-10 function. To this end, we compared the abilities of
the integrated transgenes expressing various mutant forms of
METT-10 to rescue mett-10 mutant phenotypes. These in-
cluded METT-10 with a mutant DLC-1 binding site
[mett-10(5A)::gfp], a mutant DLC-1 binding motif and deletion
of the NLS [mett-10(NLS, 5A)::gfp], and METT-10 with a
mutant DLC-1 binding site and a mutation in the catalytic core
that should reduce the methyltransferase activity [mett-
10(G110R, 5A)::gfp] (see Materials and Methods). We com-
pared expression of mRNA and protein by the various trans-
genes using qRT-PCR and Western blots (data not shown; see
Materials and Methods). The mRNA and protein levels of
wild-type and mutant transgenes are similarly correlated, sug-
gesting that METT-10(5A)::GFP is not especially unstable and
agreeing with the finding described above that DLC-1 pro-
motes METT-10 levels primarily by regulating mett-10 mRNA
levels.
Each mett-10 transgene was tested for its ability to rescue
several mett-10 mutant phenotypes, including abnormalities in
somatic and germ cell development observed in the mett-10
null background and defective proliferative fate specification
caused by loss-of-function mett-10 mutations (13). Loss of
mett-10 function causes protrusion of the vulva, irregular go-
nadal shape, and defects in germ cell development, leading to
a sterile phenotype when animals are raised at 25°C (13).
While a methyltransferase-defective transgene failed to rescue
any defects, mett-10(5A)::gfp and mett-10(NLS, 5A)::gfp
transgenes fully rescued the protruding vulva phenotype and
partially rescued abnormalities in gonad shape and germ cell
development (Table 1). This partial rescue (81% to 86% re-
duction in phenotype penetrance as opposed to 100% reduc-
tion in that for the wild-type transgene) suggests that the de-
gree of METT-10 nuclear accumulation, promoted by both
DLC-1 interaction and the NLS, facilitates METT-10 functions
but is not essential. Moreover, even in the absence of both the
DLC-1 interaction site and the NLS, some residual METT-10
may still enter the nucleus [some nuclear puncta can be seen
for mett-10(NLS, 5A)::gfp] (Fig. 5E), enabling partial rescue.
The fact that the methyltransferase-defective transgene does
not rescue any of these phenotypes demonstrates that enzy-
matic activity is required for METT-10 function, and it is
possible that even if the critical METT-10 targets are nuclear
proteins, METT-10 may also modify them in the cytoplasm
before they enter the nucleus.
Loss of mett-10 function compromises the balance between
germ cell proliferation and differentiation, which similar to this
balance in dlc-1 and dhc-1, is revealed in a glp-1 hyperactiva-
tion mutant background (13). Thus, to evaluate the role of
METT-10 nuclear accumulation in proliferative fate specifica-
FIG. 5. Dual mechanism ensures METT-10 nuclear accumulation.
(A) Domain architecture of METT-10 marked with protein sequence
change caused by mett-10(oz36) and location of the DLC-1 binding
motif. Gray shading highlights the conserved methyltransferase-10 do-
main, and purple indicates the NLC sequence. (B to F) Confocal
images (0.3 m) of wild-type and mutant METT-10::GFP expression
in gonadal sheath cells stained with antibodies against GFP and lamin
to visualize nuclear membrane.
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tion, we tested for rescue of the tumorous phenotype of the
glp-1(oz264gf) mett-10(g38) double mutants. Expression of
METT-10(5A)::GFP and METT-10(NLS, 5A)::GFP rescued
the tumorous phenotype of glp-1(oz264) mett-10(g38) animals,
but a methyltransferase-defective version of METT-10 did not
rescue the mutant phenotype (Table 1). Thus, METT-10 inhi-
bition of proliferative fate, similar to other METT-10 devel-
opmental functions, requires enzymatic activity but not the full
extent of nuclear accumulation that is mediated by its NLS and
DLC-1.
Dynein also regulates proliferative fate independently of
METT-10. Based on the above-mentioned observations, one
possible explanation for the enhancement of glp-1(oz264gf)
tumor formation by DLC-1 depletion is the reduced METT-10
accumulation caused by decreased mett-10 mRNA, combined
with decreased transport of METT-10 to the nucleus. How-
ever, genetic interactions among mett-10, dlc-1, and dhc-1 in-
dicate that dynein also plays roles in proliferative fate specifi-
cation independent of its effects on METT-10 protein
accumulation.
The role of METT-10 in proliferative fate specification was
initially revealed by the antimorphic mett-10(oz36) truncation
mutant, which exhibits germ line tumors even in the presence
of wild-type glp-1 (13). mett-10(oz36) mutants exhibit, with
respect to germ line proliferation, a phenotype that is more
severe than those exhibited by mutants lacking all mett-10
activity (13). The dose dependence of the proliferative effect of
the METT-10(oz36) truncated protein showed that it is a “poi-
sonous” protein that disrupts the function of at least one other
unknown factor that normally inhibits proliferative fate (13).
One prediction of this model is that depletion of this poisoned
factor should enhance mett-10(oz36) tumor formation. Inter-
estingly, we found that RNAi knockdown of DLC-1 enhances
tumor formation in the mett-10(oz36) genetic background (Ta-
ble 2). Moreover, two different weak loss-of-function heavy
chain alleles, dhc-1(or195) (51) and dhc-1(js319) (29, 51), also
specifically enhanced the mett-10(oz36) tumorous phenotype
(Table 2), consistent with a genetic model in which METT-
10(oz36) poisons DLC-1 activity. However, METT-10(oz36)
lacks both the DLC-1 binding site and the canonical NLS and
thus is predominantly cytoplasmic (Fig. 5A and F), indicating
that DLC-1 cannot be the poisoned factor. Thus, the ability of
DLC-1 knockdown and dhc-1 reduction-of-function mutants to
further enhance tumor formation indicates that DLC-1 also
regulates proliferative fate independently of its effects on
METT-10, potentially by promoting the activity of a factor
normally poisoned by the METT-10(oz36) mutant protein.
Dynein and METT-10 may function together in cell division
and meiosis. The dhc-1(js319) dynein heavy chain mutation did
TABLE 1. Transgenic rescue of mett-10 phenotypese
Transgenec
% Tumorous germ






Animals scored % Abnormal gonad
shape (no.)a% Pvl % Ste No.
No transgene 0 (96) 89 (47) 98 99 82 30 (44)
met-10(wt)::gfp 0 (136) 0 (56) 5 0** 38 0 (35)
mett-10(5A)::gfp (LOW) 0 (86) 0 (54) 65 19** 43 ND
mett-10(5A)::gfp (HIGH) 0 (36) ND 1 0** 137 3 (32)**
mett-10 (enzymatic-defective, 5A)::gfp (line 1) 0 (36) 91 (84) 92 98 46 30 (43)
mett-10 (enzymatic-defective, 5A)::gfp (line 2) 0 (48) 94 (83) 97 99 97 ND
mett-10(NLS, 5A)::gfp (line 1) 0 (37) 4.3 (94) 0 19** 42 10 (31)**
mett-10(NLS, 5A)::gfp (line 2) ND ND 0 14** 36 12 (25)
a Gonads with one or more ectopic distal protrusions.
b , two-tailed P value and Fisher’s exact test value of 	0.05 were significantly different from no transgene. Pvl, protruding vulva; Ste, sterile. Scored by DIC.
c LOW and HIGH refer to low and high mRNA and protein expression levels, respectively, as measured by IP and qRT-PCR (data not shown).
d Tumorous includes proliferation throughout the germ line, although some germ cells in various meiotic stages may be observed. Scored by DIC.
e ND, not determined.
TABLE 2. Dynein disruption enhances tumor formation in the





rrf-1(pk1417) mett-10(oz36) gfp(RNAi) 3 117
rrf-1(pk1417) dlc-1(RNAi) 0 122





dhc-1(or195) glp-1(oz264) 9 22
dhc-1(or195) mett-10(tm2697) 0 35
dhc-1(or195) mett-10(g38) 0 18
dhc-1(or195) mett-10(oj32) 0 26
dhc-1(or195) mett-10(ok2204) 0 65
dhc-1(or195) mett-10(oz36) 100** 46
dhc-1(or195) glp-1(bn18) mett-10(oz36) 0 38
dhc-1(js319) 0 26
dhc-1(js319) glp-1(oz264) 6 17
dhc-1(js319) mett-10(tm2697) 0 59
dhc-1(js319) mett-10(g38) 0 40
dhc-1(js319) mett-10(oj32) 0 30
dhc-1(js319) mett-10(ok2204) 0 24
dhc-1(js319) mett-10(oz36) 76** 42
dhc-1(js319) glp-1(bn18) mett-10(oz36) 0 52
a For all genotypes, animals were m
 z
, i.e., came from homozygous mutant
mothers. rrf-1(pk1417) enables germ line restricted RNAi. All RNAi and scoring
was carried out at 20°C.
b For all genotypes, all animals were m z
, i.e., came from mothers carrying
a wild-type copy of mett-10, and were scored at 2 days past L4 at 20°C by
dissection and DAPI (4,6-diamidino-2-phenylindole) staining.
c , significance as calculated by Fisher’s exact test, using mett-10(oz36) alone
for expected values.
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not cause tumors when combined with loss-of-function mett-10
alleles, but the double mutant animals had a fully penetrant
sterility not seen in either mutant alone. On closer examina-
tion, dhc-1(js319) mett-10 germ lines exhibited the following
two primary defects reminiscent of the phenotypes caused by
RNAi knockdown of DLC-1: polyploidy in the distal region
and unpaired chromosomes in diakinesis (Fig. 6 and Table 3).
We also saw these phenotypes at low levels of penetrance in
dhc-1(js319) animals, but they are distinct from the cell cycle
progression defects observed in mett-10 single mutants (13).
Thus, loss of mett-10 function enhances a hypomorphic dhc-1
allele, causing phenotypes typical of dynein loss-of-function
mutations. This indicates that METT-10 also facilitates the
function of the dynein motor complex in cell division and
meiosis. Complete loss of mett-10 function alone does not
cause these phenotypes, indicating that mett-10 function in cell
division and meiotic events is not essential unless dynein func-
tion is partially compromised.
Reduction in glp-1 activity suppresses germ line overprolif-
eration but not the polyploidy and unpaired chromosome phe-
notypes of dhc-1 mett-10(oz36) double mutants (Tables 2 and
3). Thus, the roles of mett-10 and dynein in cell division and
meiotic events can be separated from their roles in regulation
of the proliferative fate decision. We conclude, therefore, that
regulation of proliferative fate, perhaps through negative reg-
ulation of glp-1 signaling, is only one cellular function in which
dynein and METT-10 cooperate.
DISCUSSION
Dynein inhibits specification of proliferative fate in the C.
elegans germ line. The genetic and molecular studies presented
here demonstrate that the dynein motor protein complex in-
hibits the decision of germ cells to proliferate in the C. elegans
germ line, despite being necessary for the execution of mitotic
cell division in those cells that do proliferate. The evidence
further indicates that dynein regulates this cell fate decision in
part by promoting the expression and function of the
METT-10 putative methyltransferase that inhibits proliferative
fate and in part through a METT-10-independent pathway.
DLC-1 regulates METT-10 RNA levels and protein subcel-
lular localization. DLC-1 knockdown reduces both METT-10
mRNA and protein levels. The mammalian LC8-type dynein
light chain, DLC-1, localizes to chromatin and acts in a tran-
scriptional transactivation complex with the estrogen receptor
(46), raising the possibility that DLC-1 could directly regulate
mett-10 transcription. It is also possible that DLC-1 normally
promotes mett-10 mRNA stability or enables the nuclear lo-
FIG. 6. mett-10 mutants enhance dynein loss-of-function phenotypes of the dhc-1(js319) allele. (A, C, and D) Most dhc-1(js319) mutant germ
lines are relatively normal at both 20 and 25°C, although they exhibit polyploidy (large DNA-dense nuclei) and univalents (unpaired chromosomes
in diakinesis) at very low penetrance. (B, E, and F) Double mutations between dhc-1(js319) and any mett-10 allele lead to significant enhancement
of both these phenotypes, and all double mutant animals are sterile at 20°C. This set of phenotypes closely phenocopies loss of dlc-1 function in
the germ line.
TABLE 3. mett-10 loss-of-function alleles enhance mitotic and
meiotic defects of a dhc-1 allele
Genotype







dhc-1(js319) 4 4 26
dhc-1(js319) glp-1(oz264) 5 0 19
dhc-1(js319) mett-10(tm2697) 100 42 59
dhc-1(js319) mett-10(g38) 100 30 40
dhc-1(js319) mett-10(ok2204) 92 8 24
dhc-1(js319) mett-10(oj32) 97 3 30




a Polyploid nuclei are very large and stain intensely with the DNA dye DAPI.
These are distinct from the enlarged, weakly DAPI-staining nuclei indicative of
cell cycle arrest observed in mett-10 single mutants (13). All animals were m z
,
i.e., came from mothers carrying a wild-type copy of mett-10, and were scored at
2 days past L4.
b NA, not applicable; as germ lines are tumorous.
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calization of other proteins that ensure adequate mett-10 tran-
scription. Regulation of mett-10 mRNA levels is likely to be the
primary mode of METT-10 regulation by DLC-1 and may
significantly contribute to the overproliferation phenotype ob-
served when dlc-1 is depleted in the glp-1(oz264) background.
The direct physical interaction between DLC-1 and
METT-10 reported here appears to play a redundant, nones-
sential role in METT-10 function. We showed that NLS-me-
diated and dynein-mediated pathways act redundantly to en-
sure normal METT-10 nuclear accumulation. The role of
dynein and the microtubule network, and specifically LC8-type
light chains, in facilitating the nuclear import of proteins is well
documented (11, 16, 37, 48, 54, 57). However, in cases where it
has been examined, dynein mediates nuclear accumulation by
enhancing the efficiency of NLS-dependent nuclear import (37,
48). In these cases, unlike the example of METT-10, nuclear
accumulation still requires an intact NLS. Thus, our work
reveals a qualitatively different role for dynein, and LC8/
DLC-1 interaction, in mediating nuclear accumulation. We
cannot rule out the possibility, however, that DLC-1 also spe-
cifically promotes the function of a secondary, noncanonical
NLS in METT-10.
When we specifically disrupted NLS- and DLC-1-mediated
METT-10 nuclear accumulation in vivo, we found that it plays
a nonessential role in most mett-10 developmental functions.
Because our double mutants still retain some residual nuclear
METT-10, a small nuclear pool may be sufficient to carry out
its function as a methyltransferase. It is also possible that
METT-10 association with dynein is transient and promotes
modification of target molecules on their way to the nucleus,
with METT-10 nuclear accumulation as a by-product. In this
scenario, cytoplasmic METT-10 would be able to modify tar-
gets in the cytoplasm before their transport to the nucleus.
While DLC-1 may inhibit proliferative fate in part through
promotion of normal METT-10 activity, it is clear that DLC-1
(and dynein) inhibit proliferative fate by other means as well,
since disruptions in dynein function enhance germ line tumor
formation of the mett-10(oz36) cytoplasmic mutant. Interest-
ingly, disruptions of dynein function do not cause germ line
tumors in other mett-10 mutant backgrounds, including the
null. Since METT-10(oz36) is proposed to “poison” the func-
tion of another gene product through an unproductive physical
association (13), it is possible that dynein promotes the normal
function of the gene product(s) poisoned by METT-10(oz36),
thus sensitizing mett-10(oz36) to perturbations in dynein func-
tion. Moreover, it is possible that METT-10, dynein, and this
“poisoned factor” function to negatively regulate the propro-
liferative GLP-1/Notch signaling functions, as the mett-
10(oz36) dhc-1(or195) tumors are exquisitely sensitive to the
levels of glp-1 activity.
Dynein and METT-10 function together in multiple con-
texts. While METT-10 and the dynein motor complex function
together to inhibit germ cell proliferative fate, we also uncov-
ered a role for METT-10 in other dynein-dependent processes.
Specifically, decreases in METT-10 activity enhance the mi-
totic and meiotic defects of a weak dynein heavy chain loss-of-
function allele, leading to highly penetrant sterility, polyploidy,
and unpaired chromosomes in diakinesis. Interestingly,
O’Connell and colleagues identified a phenotype in mett-
10(oj32) loss-of-function mutants similar to those seen in dy-
nein loss-of-function mutants (41). Specifically, mett-10(oj32)
embryos have a visible defect in the flattening of the posterior
centrosome during the first asymmetric division (41). The func-
tion of centrosome flattening is unclear but may be caused by
the dynein-dependent force that pulls the posterior centro-
some toward the posterior pole, thus ensuring asymmetric di-
vision (40, 53). Importantly, defects in centrosome flattening
are also observed for perturbations in dynein and dynactin
function, as well as genetic disruption of dynein-interacting
proteins (8, 40, 51, 53, 55).
The genetic interactions between mett-10, dlc-1, and dhc-1 in
proliferative fate specification, mitotic cell division, and meio-
sis suggest that these different cellular functions may have a
common underlying mechanism. However, the experiments
presented here also delineate a role for DLC-1 in promoting
METT-10 activity during proliferative fate specification and a
role for METT-10 in promoting DLC-1 activity during cell
division and meiotic pairing and/or recombination. The most
parsimonious interpretation of these findings is that METT-10
promotes DLC-1 activity, which in turn promotes METT-10
function in a positive feedback loop.
How could METT-10 affect DLC-1 function? DLC-1 is an
LC8-type dynein light chain, which exists as a dimer when
associated with the dynein motor complex (58). Two models
have been proposed for the role of the LC8 dynein light chain
with respect to the dynein motor complex. One model suggests
that LC8 dimers act as dimerization hubs, binding to regions of
intrinsic disorder in a diverse set of proteins, leading to in-
creased structural organization and dimerization (2, 59). This
model proposes that LC8 promotes normal dynein function by
promoting dimerization of the dynein intermediate chain (2,
28). Indeed, since METT-10 can simultaneously bind to itself
and to DLC-1, it is possible that DLC-1 promotes METT-10
dimerization in vivo. A second model proposes that DLC-1/
LC8 functions as a cargo adaptor molecule, enabling the asso-
ciation of the dynein motor complex with a wide spectrum of
proteins (25, 30, 38). The unifying theme of both models is that
DLC-1 carries out multiple cellular functions by binding to and
regulating the function of a diverse set of target proteins. It is
possible that METT-10 methylates targets of the dynein motor
complex and that this methylation event promotes their asso-
ciation with DLC-1 or the motor complex. Alternatively,
DLC-1 and METT-10 could coordinately regulate target pro-
teins by coupling multiple modes of regulation, such as post-
translational modification and subcellular localization. In both
cases, association with dynein would enhance METT-10 func-
tion but may not be essential.
Proliferative and antiproliferative roles of dynein. The dy-
nein motor complex participates in a diversity of processes,
including nuclear movements, spindle assembly and orienta-
tion, mitotic checkpoint inactivation, organelle movement, and
endocytosis (20, 25). Here we show that dynein inhibits the
specification of germ cell proliferative fate, despite also being
necessary for mitotic cell division in proliferating cells. These
“antiproliferative” (cell fate) and “proproliferative” (cell fate
execution/cell division) functions of dynein are not unique to
the maintenance of the balance between proliferation and dif-
ferentiation in the C. elegans germ line. The essential roles of
dynein in the execution of cell division are well known (25), as
is its role in promoting the activity of tumor suppressors, in-
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cluding p53, by facilitating their nuclear transport (14, 16, 48,
57). Moreover, in keeping with its many cellular functions, the
dynein motor complex influences multiple cell fate decisions by
a diversity of mechanisms. These include the trafficking of cell
fate determinants, such as egalitarian and its associated oskar
mRNA (38), spindle positioning during asymmetric division (8,
40), ensuring the normal timing of mitotic cell division (15),
and now, promoting RNA levels and protein nuclear accumu-
lation of a factor influencing cell fate. Thus, dynein acts as a
“handyman,” performing many of the jobs necessary to execute
a developmental program.
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